Researchers at Stanford devised a strange new molecule that could lead to drugs that arm genes and make cancers work against themselves. https://www.nytimes.com/2023/07/26/health/cancer-self-destruct.html An article in the New York Times by Gina Kolata featuring the design and development by the Crabtree and Gray lab of small molecules (TCIP, Transcriptional/Epigenetic Chemical Inducers of Proximity) that rewire cancer drivers to activate powerful and precise cell death pathways (apoptosis). These molecules hold the promise of making far more specific and less toxic therapies for cancers with identified drivers.